Department of Pediatric Otolaryngology, Montreal Children's Hospital, McGill University Health Centre, 1001 Decarie, H4A 3J1, Montreal, Quebec, Canada.
Department of Pediatric Otolaryngology - Head and Neck Surgery, CHU Lille, F-59000, Lille, France.
Int J Pediatr Otorhinolaryngol. 2024 Jun;181:111960. doi: 10.1016/j.ijporl.2024.111960. Epub 2024 Apr 27.
Recurrent and primary tracheoesophageal fistulas (TEFs) are a challenging surgical pathology to treat, as standard open surgical approaches are associated with high morbidity and mortality. As such, endoscopic modalities have gained interest as an alluring alternative, yet variable success rates have been reported in the literature. The aim of this study was to provide a contemporary update of the literature and describe our institutional experience with the bronchoscopic obliteration of recurrent and primary TEFs.
Retrospective chart review of all pediatric patients having undergone endoscopic TEF repair at two pediatric academic centers in Montreal, Canada and Lille, France between January 1, 2008 to December 31, 2020.
28 patients with TEFs (20 recurrent, 8 primary) underwent a total of 48 endoscopic procedures. TEF repair was performed under endoscopic guidance using various combinations of techniques, including fistula de-epithelialization (endoscopic brush, thulium laser, trichloroacetic acid-soaked pledgets or electrocautery), tissue adhesives, submucosal augmentation, esophageal clip and stenting. Successful closure was achieved in 16 patients (57 %), while 12 (43 %) required eventual open or thoracoscopic repair. The mean number of endoscopic procedures was 1.7. There were no major treatment-related complications such as pneumothorax, mediastinitis or death (mean follow-up 50.8 months).
Endoscopic repair of recurrent or primary TEFs is a valuable component of our therapeutic armamentarium and may contribute to decreased surgical morbidity in this complex patient population. Families should be counselled that endoscopic results may be more modest than with open or thoracoscopic approaches, and multiple procedures may be required.
复发性和原发性气管食管瘘(TEF)是一种具有挑战性的外科病理学治疗方法,因为标准的开放式手术方法与高发病率和死亡率相关。因此,内镜方法作为一种有吸引力的替代方法引起了人们的兴趣,但文献中报道的成功率各不相同。本研究旨在提供该领域的最新文献综述,并描述我们机构在支气管镜下治疗复发性和原发性 TEF 的经验。
对 2008 年 1 月 1 日至 2020 年 12 月 31 日期间,在加拿大蒙特利尔和法国里尔的两家儿科学术中心接受内镜 TEF 修复的所有儿科患者的病历进行回顾性分析。
28 例 TEF 患者(20 例复发性,8 例原发性)共进行了 48 次内镜手术。TEF 修复在内镜引导下进行,使用各种技术组合,包括瘘管去上皮化(内镜刷、钬激光、三氯乙酸浸泡的敷料或电烙术)、组织粘合剂、黏膜下增强、食管夹和支架。16 例患者(57%)成功闭合,12 例(43%)最终需要开放性或胸腔镜修复。内镜手术的平均次数为 1.7 次。无气胸、纵隔炎或死亡等重大治疗相关并发症(平均随访 50.8 个月)。
复发性或原发性 TEF 的内镜修复是我们治疗手段的一个有价值的组成部分,可能有助于降低这类复杂患者的手术发病率。应告知患者家属,内镜治疗的效果可能不如开放性或胸腔镜方法,可能需要多次手术。